Design and synthesis of substituted compounds containing the 1,4- benzodioxin subunit. New potential calcium antagonists

European Journal of Medicinal Chemistry

Volumn 35, Issue 7-8, 2000, Pages 663-676

  Sánchez, Isabel ^a   Dolors Pujol, Maria ^a   Guillaumet, Gerald ^b   Massingham, Roy ^c   Monteil, André ^d   Dureng, Georges ^d   Winslow, Eileen ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c UCB PHARMA   (Belgium)

^d CERM Centre Europeen de Recherches Mauvernay   (France)

Author keywords

1,4 benzodioxin; 2,3 dihydro 1,4 benzodioxin; Calcium channel antagonists; Calmodulin antagonists

Indexed keywords

1,4 BENZODIOXIN DERIVATIVE; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CALMODULIN INHIBITOR; DILTIAZEM; FENDILINE; FLUNARIZINE; NIFEDIPINE; PRAZOSIN; RYANODINE; VERAPAMIL;

ALKYLATION; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM ANTAGONISM; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; REDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0037781728     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00164-1     Document Type: Article

References (22)

1. Chatelain P., Massingham R. Eur. J. Med. Chem. 32:1997;687-707.
2. Campiani G., Fiorini I., De Filippis M.P., Ciani S.M., Garofalo A., Nacci V., et al. J. Med. Chem. 39:1996;2922-2938.
3. Corelli F., Manetti F., Tafi A., Campiani G., Nacci V., Botta M. J. Med. Chem. 40:1997;125-131.
4. Hubbard J.W., Kapples J.F., Nordstrom S.T., Matson L.C., Wilson S.J., Ress R.J., et al. Drug Dev. Res. 15:1988;17-29.
5. Bourlot A.S., Sánchez I., Dureng G., Guillaumet G., Massingham R., Monteil A., et al. J. Med. Chem. 41:1998;3142-3158.
6. Koo J., Avakian S., Martin G.J. J. Am. Chem. Soc. 77:1955;5373-5375.
7. Coudert G., Guillaumet G., Loubinoux B. Tetrahedron Lett. 1978;1059-1062.
8. Khouili M., Guillaumet G., Coudert G., Pujol M.D. Il Farmaco. 51:1996;175-184.
9. Khouili M., Guillaumet G., Coudert G., Pujol M.D. Il Farmaco. 51:1996;185-188.
10. Klunder J.M., Ko S.Y., Sharpless K.B. J. Org. Chem. 51:1986;3710-3712.
11. Caputo J.F., Martin A.R., Mallick S.K. J. Org. Chem. 39:1974;1808-1811.
12. Guillaumet G., Coudert G., Ponchant M., Beaucourt J.P., Pichat L. J. Label. Compd. Radiopharm. 21:1984;161-172.
13. Adam W., Peters E.M., Peters K., Platsch H., Schmidt E., Von Schnering H., Takayama K. J. Org. Chem. 49:1984;3920-3928.
14. Vo D., Matowe W.C., Ramesh M., Iqbal N., Wolowyk M.W., Howlett B.E., Knaus E.E. J. Med. Chem. 38:1995;2851-2859.
15. Adams T.C., Dupont A.C., Carter J.P., Kachur J.F., Guzewska M.E., Rzeszotarski W.J., et al. J. Med. Chem. 34:1991;1585-1593.
16. Iqbal N., Knaus E. Arch. Pharm. (Weinheim). 329:1996;408-412.
17. Shupnik M.A., Weck J., Hinkle P.M. Mol. Endocrinol. 10:1996;90-90.
18. Prous J.R. The Year's Drug News Therapeutic Targets; Prous Science Publishers, Barcelona. 1994;168-174.
19. Asano T., Hidaka H. Methods Find. Exp. Clin. Pharmacol. 12:1990;443-443.
20. Inagaki M., Tanaka T., Hidaka H. Pharmacology. 27:1983;125-125.
21. Winslow E., Farmer S., Martorana M., Marshall R.J. Eur. J. Pharmacol. 131:1986;219-228.
22. John G.W., Fàbregues E., Kamal M., Massingham R. Eur. J. Pharmacol. 196:1991;307-312.